Moneycontrol
    Moneycontrol PRO
    LAMF
    LAMF

    Thyrocare

    Jump to

    • Thyrocare promoter Docon Technologies sells 10% stake for Rs 668 crore; stock up 1.6%

      Thyrocare Technologies promoter group entity Docon Technologies has sold over 10 percent equity stake in open markets for about Rs 668 crore.

    • Thyrocare's Velumani urges recruiters to hire poor and humble employees 'for long term success'

      Drawing from experience, Thyrocare CEO A Velumani suggests hiring humble individuals for business success, a sentiment shared by Zoho's Sridhar Vembu regarding untapped rural talent.

    • 'Troll me as much as you enjoy': Thyrocare CEO after post on riding OLA cabs instead of luxury cars

      The founder and CEO of the medical laboratory company had on Saturday shared that his frugality has shocked his peers after an event at a 5-star hotel recently.

    • Thyrocare shares jump 6% after firm's Q3 net profit rises 24% to Rs 19 crore

      Thyrocare reported 23% YoY rise in revenue in December quarter

    • PharmEasy co-founders Dharmil Sheth, Dhaval Shah, Harsh Parekh and Hardik Dedhia to leave troubled startup

      The founder group cumulatively holds under 2 percent in API Holdings. Each of the five co-founders held between 0.20 percent to 0.30 percent stake in the company, data showed.

    • Thyrocare Q3 results: Net profit flat at Rs 14.74crore

      Revenue came in at Rs 134.7 crore, up 5.2 percent from the year-ago quarter

    • Diagnostics players have become rational in terms of pricing: Thyrocare CEO

      Throcare had normalised EBITDA of 30 percent in Q2 of FY24 and in the same period the previous year.

    • Thyrocare Q2 results: Net profit up 31.75% to Rs 20.33 crore

      The company reported a profit of Rs 15.43 crore in the same period last year.

    • Stock Market Live: Covid Fears Hurting Markets. Will The Selloff Continue? RIL, Thyrocare In Focus

    • Stock Market Live: Diagnostics Stocks Back In Limelight Amid Covid Fears. Can The Momentum Sustain?

    • Discovery series: Is it time to start looking at this quality diagnostic service?

    • Stock Market Live: Nifty below 17,350 – more correction likely? Thyrocare, BLS and Orient Cement in focus

    • Thyrocare founder wants to invest 'minimum Rs 100 crore' in goat farming business

    • Thyrocare unveils new brand identity with a change in logo

    • Thyrocare boss recalls how he was asked to compare himself to fallen Silicon Valley star Elizabeth Holmes

    • Dr Lal Pathlab – Suburban Diagnostic deal - a marriage made in a Petri dish

    • PharmEasy raises $350 million in pre-IPO round: Report

    • Vijaya Diagnostic: What does this regional player offer amid industry consolidation?

    • Trend of omni-channel transactions like PharmEasy-Thyrocare here to stay, says ace dealmaker Sourav Mallik of Kotak

    • Emotional Dr Velumani says he “moved fast for a change” as he sold Thyrocare to PharmEasy

    • Pharmeasy raises additional $300 million from investors, aims for IPO in 6-18 months

    • PharmEasy to acquire 66.1% stake in Thyrocare for Rs 4,546 crore

    • Exclusive | PharmEasy in talks to acquire Thyrocare for Rs 7,000 crore

    • Exclusive | PharmEasy in talks to buy Thyrocare for around Rs 7,000 crore

    • Emerging healthcare trends put diagnostics sector in a sweet spot, IIFL Sec recommends buy on Metropolis, Thyrocare

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347